AZRXのチャート
AZRXの企業情報
| symbol | AZRx |
|---|---|
| 会社名 | AzurRx BioPharma Inc （アズ―ルレックス・バイオファ―マ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | 医薬品 医療関連（Health Care） |
| 概要 | 事業概要 Azurrxバイオファーマ(Azurrx Biopharma Inc.)は胃腸障害患者を治療するための非全身生物製剤の研究・開発に従事する会社である。同社の製品ラインは｢MS1819｣と｢AZX1101｣という治療用タンパク質を含む。｢MS1819｣は慢性膵炎(CP)及び嚢胞性線維症(CF)患者に関連する膵外分泌機能不全(EPI)への治療のための自己(同じ生物からの) 酵母組換えリパーゼである。｢AZX1101｣はbラクタム系抗生物質の非経口投与によって誘発された耐性細菌株による院内感染の防止、並びに抗生物質関連下痢症(AAD)の予防用の細菌由来の組み換えbラクタマーゼの結合である。同社の｢MS1819｣は完了したフェーズI/ IIa臨床試験を有し、フェースIIb臨床試験を開始することに焦点を当てる。 アズ―ルレックス・バイオファ―マは米国のバイオ医薬品企業。主に、胃腸疾患に対する非全身性のバイオ医薬品の研究開発に従事する。腸ル―メンなどの粘膜による体内循環ではなく、患部で作用する非吸収性薬で、同社パイプラインに外分泌性膵不全の治療薬「MS1819」などがある。本社はニューヨーク州ブルックリン。 AzurRx BioPharma, Inc. is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company has a pipeline of three gut-restricted GI assets. The lead therapeutic candidate is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis and chronic pancreatitis, currently in two Phase 2 clinical trials. AzurRx is launching two clinical programs using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor, FW-420, for grade 1 Immune Checkpoint Inhibitor Colitis and diarrhea in oncology patients and FW-1022, for COVID-19 gastrointestinal infections. The Company is headquartered in Delray Beach, Florida with clinical operations in Hayward, California. |
| 本社所在地 | 760 Parkside Avenue Downstate Biotechnology Incubator Suite 304 Brooklyn NY 11226 USA |
| 代表者氏名 | Edward J. Borkowski エドワードJ.ボルコウスキ |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 646-699-7855 |
| 設立年月日 | 41640 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | 2016年 |
| 従業員数 | 13人 |
| url | www.azurrx.com |
| nasdaq_url | https://www.nasdaq.com/symbol/azrx |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -11.09270 |
| 終値（lastsale） | 2.48 |
| 時価総額（marketcap） | 41937945.76 |
| 時価総額 | 時価総額（百万ドル） 37.87943 |
| 売上高 | 売上高（百万ドル） 0.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 30.74134 |
| 当期純利益 | 当期純利益（百万ドル） -12.55741 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 AzurRx BioPharma Inc revenues was not reported. Net loss increased 27% to $6.9M. Higher net loss reflects Research and development expenses increase from $1.3M to $2.6M (expense) General_administrative expenses - Bal increase of 27% to $4.1M (expense) Depreciation in SGA increase of 32% to $30K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.56 to -$0.51. |
AZRXのテクニカル分析
AZRXのニュース
Whats Better? Buy or Sell: AzurRx BioPharma, Inc. (NASDAQ:AZRX), SCWorx Corp. (NASDAQ:WORX) 2021/07/27 00:29:59 Stock Equity
AzurRx BioPharma, Inc. (AZRX) with the stream of -1.00% also noticed, India SCWorx Corp. (WORX) encountered a rapid change of -4.15% in the last hour of Mondays trading session. AzurRx The post Whats Better? Buy or Sell: AzurRx BioPharma, Inc. (NASDAQ:AZRX), SCWorx Corp. (NASDAQ:WORX) appeared first on Stocks Equity .
AzurRx BioPharma Advances Phase 2 Trial, Broad Indications Include Potential Treatment For COVID-19 Delta Variant Related GI Infections (NASDAQ: AZRX) 2021/07/26 10:36:01 AB Newswire
Flashy Stock: AzurRx BioPharma, Inc. (NASDAQ:AZRX), Energy Transfer LP (NYSE:ET) 2021/07/23 22:42:29 Stock Equity
AzurRx BioPharma, Inc. (AZRX) with the stream of -21.28% also noticed, India Energy Transfer LP (ET) encountered a rapid change of -0.91% in the last hour of Fridays trading session. The post Flashy Stock: AzurRx BioPharma, Inc. (NASDAQ:AZRX), Energy Transfer LP (NYSE:ET) appeared first on Stocks Equity .
Thinking about buying stock in TAL Education, Chembio Diagnostics, AzurRx BioPharma, Summit Wireless Technologies, or General Electric? 2021/07/23 14:50:00 PR Newswire
NEW YORK, July 23, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TAL, CEMI, AZRX, WISA, and GE. To see how InvestorsObserver''s proprietary scoring system rates these stocks, view the InvestorsObserver''s PriceWatch Alert by selecting the corresponding link.
Stocks Volume Buzz: AzurRx BioPharma, Inc. (NASDAQ:AZRX), The Procter & Gamble Company (NYSE:PG) 2021/07/08 23:13:57 Stock Equity
AzurRx BioPharma, Inc. (AZRX) with the stream of 1.95% also noticed, India The Procter & Gamble Company (PG) encountered a rapid change of -0.07% in the last hour of Thursdays The post Stocks Volume Buzz: AzurRx BioPharma, Inc. (NASDAQ:AZRX), The Procter & Gamble Company (NYSE:PG) appeared first on Stocks Equity .
Stock Buzzers: Beyond Meat, Inc. (NASDAQ:BYND), AzurRx BioPharma, Inc. (NASDAQ:AZRX) 2021/07/08 02:26:16 Stock Equity
Beyond Meat, Inc. (NASDAQ:BYND) with the stream of -3.60% also noticed, India AzurRx BioPharma, Inc. (NASDAQ:AZRX) encountered a rapid change of -1.25% in the last hour of Wednesday’s trading session. … The post Stock Buzzers: Beyond Meat, Inc. (NASDAQ:BYND), AzurRx BioPharma, Inc. (NASDAQ:AZRX) appeared first on Stocks Equity .
Volume Buzz: AzurRx BioPharma, Inc. (NASDAQ:AZRX), Avino Silver & Gold Mines Ltd. (AMEX:ASM) 2021/07/06 04:26:43 Stock Equity
AzurRx BioPharma, Inc. (NASDAQ:AZRX) with the stream of -1.85% also noticed, India Avino Silver & Gold Mines Ltd. (AMEX:ASM) encountered a rapid change of 0.00% in the last hour of The post Volume Buzz: AzurRx BioPharma, Inc. (NASDAQ:AZRX), Avino Silver & Gold Mines Ltd. (AMEX:ASM) appeared first on Stocks Equity .
AzurRx BioPharma Back In Focus As Data Showing COVID-19 GI Infection Rates Can Linger For Years (NASDAQ: AZRX) 2021/06/30 11:18:01 AB Newswire
Eye-catching Stock Analysis: 9 Meters Biopharma, Inc. (NASDAQ:NMTR), AzurRx BioPharma, Inc. (NASDAQ:AZRX) 2021/06/27 23:17:57 Stock Equity
9 Meters Biopharma, Inc. (NASDAQ:NMTR) with the stream of -11.11% also noticed, India AzurRx BioPharma, Inc. (NASDAQ:AZRX) encountered a rapid change of 1.20% in the last hour of trading session. The post Eye-catching Stock Analysis: 9 Meters Biopharma, Inc. (NASDAQ:NMTR), AzurRx BioPharma, Inc. (NASDAQ:AZRX) appeared first on Stocks Equity .
AzurRx BioPharma Back In Focus As Data Showing COVID-19 GI Infection Rates Can Linger For Years (NASDAQ: AZRX) 2021/06/30 11:18:01 AB Newswire
Eye-catching Stock Analysis: 9 Meters Biopharma, Inc. (NASDAQ:NMTR), AzurRx BioPharma, Inc. (NASDAQ:AZRX) 2021/06/27 23:17:57 Stock Equity
9 Meters Biopharma, Inc. (NASDAQ:NMTR) with the stream of -11.11% also noticed, India AzurRx BioPharma, Inc. (NASDAQ:AZRX) encountered a rapid change of 1.20% in the last hour of trading session. The post Eye-catching Stock Analysis: 9 Meters Biopharma, Inc. (NASDAQ:NMTR), AzurRx BioPharma, Inc. (NASDAQ:AZRX) appeared first on Stocks Equity .
Stock on the Run: AzurRx BioPharma, Inc. (NASDAQ:AZRX), AIM ImmunoTech Inc. (AMEX:AIM) 2021/06/18 23:06:01 Stock Equity
AzurRx BioPharma, Inc. (NASDAQ:AZRX) with the stream of -2.66% also noticed, India AIM ImmunoTech Inc. (AMEX:AIM) encountered a rapid change of -0.47% in the last hour of Fridays trading session. The post Stock on the Run: AzurRx BioPharma, Inc. (NASDAQ:AZRX), AIM ImmunoTech Inc. (AMEX:AIM) appeared first on Stocks Equity .
Earnings and Growth Analysis : AzurRx BioPharma (NASDAQ:AZRX) 2021/06/11 14:37:00 Stock Market Daily
Earnings results for AzurRx BioPharma , Analyst Opinion on AzurRx BioPharma , Earnings and Valuation of (NASDAQ:AZRX), Stock market Insights & financial analysis, Best stock to invest, Investment Idea, The post Earnings and Growth Analysis : AzurRx BioPharma (NASDAQ:AZRX) appeared first on .
Stocks Volume Buzz: ToughBuilt Industries, Inc. (NASDAQ:TBLT), AzurRx BioPharma, Inc. (NASDAQ:AZRX) 2021/06/09 21:47:49 Stock Equity
ToughBuilt Industries, Inc. (NASDAQ:TBLT) with the stream of 6.22% also noticed, India AzurRx BioPharma, Inc. (NASDAQ:AZRX) encountered a rapid change of 1.05% in the last hour of trading session. ToughBuilt The post Stocks Volume Buzz: ToughBuilt Industries, Inc. (NASDAQ:TBLT), AzurRx BioPharma, Inc. (NASDAQ:AZRX) appeared first on Stocks Equity .